Smith and Nephew continues recent growth in third quarter of 2016

Smith and Nephew has experienced further revenue growth during the third quarter of 2016, with recent product launches helping to drive momentum.

The company's revenue total for the quarter came to $1.12 billion (949.58 million pounds), up by two percent on an underlying basis and one percent on a reported basis. Both established and emerging markets contributed to this performance.

Its sports medicine joint repair and knee implant businesses were key drivers of growth during the quarter, with positive customer reactions to seen to recent product introductions.

These included the new camera and Coblation systems launched for sports medicine customers, plus the expanded launch of the Journey II Total Knee System and the Navio robotics platform.

Additionally, the $350 million divestment of its gynaecology business was completed during the quarter, with an associated $300 million share buyback now underway.

Olivier Bohuon, chief executive officer of Smith and Nephew, said: "The third quarter saw a continuation of many of the trends seen in the previous period."

With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.